|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 96924367.4 (espacenet) (Federated) (European Patent Register), 19960708 | | Patent/reg. no. and date | DK/EP 0848704, 20011024 | | Publication date | 19980624 | | Priority no. and date | US 601454, 19950717 | | EP pub. no. and date |
EP 0848704 19980624 | | Effective date | | | Applicant/owner | Warner-Lambert Company LLC, 235 East 42nd Street
New York, NY 10017, US | | Applicant ref. no. | 106392 | | Inventor | MCKENZIE, Ann, T., 1932 Happy Hollow Road
West Lafayette, IN 47906, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/40 (2006.01) , C07D 207/34 (2006.01) | | Title | Krystallinsk form III af hemi-calciumsaltet (atorvastatin) af [R-(R*,R*)]-2-(4-fluorphenyl)-beta-delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carboxyl]-1H-pyrrol-1-heptansyre | | Int. application no. | US1996011367 | | Int. publication no. | WO1997003958 | | Related patent (certificate) | | | Status | Ændret EP patent ikke valid i DK | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
